Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia. [Phase 2]

View source ↗

Summary

A phase 2 clinical trial to evaluate the efficacy and safety of Navepegritide in adolescents (12-18) with Achondroplasia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• Navepegritide (Navepegritide)

Snippet

Sponsor: Ascendis Pharma A/S | Conditions: Achondroplasia | Phase 2 | Status: RECRUITING